Consumer staples behemoth Clorox (NYSE: CLX) has faced no shortage of issues over the last few years. With ballooning inflation and a cyberattack hampering Clorox's operations (among many other companies), the company's stock still languishes 33% below its all-time highs from 2020.
However, despite facing these challenges, Clorox still grew sales by 17% over the past five years. This growth highlights the nondiscretionary nature of its products -- they will be purchased regardless of the challenging macroeconomic environment.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks »
This sales stability, paired with Clorox's ongoing turnaround yet depressed share price, makes it a steady-Eddie stock worth a long look today. With the company (and its 3% dividend yield) well on its way to becoming a Dividend King, I believe this magnificent stock offers the potential for a lifetime of passive income.
The central investment thesis for owning Clorox stock is that it is home to over a dozen market-leading brands. In fact, roughly 80% of its sales come from brands that hold a No. 1 or No. 2 market share in their product category. Here is a look at the company's most prominent brands in each of its business segments:
This dominant positioning across several consumer staples categories has helped Clorox roughly match the S&P 500's total returns since the turn of the century. These returns come in spite of a cyberattack in 2023 that caused the company to halt production at many of its manufacturing facilities and sent its stock down over 30%.
While this attack disrupted Clorox's product distribution and interrupted its five-year, $500 million enterprise resource platform changeover and transition to the cloud, the company is almost back to "normal" one year later. CEO Linda Rendle spoke to this point at the company's last earnings call, explaining:
We entered fiscal 2025 in a position of operational strength, having fully restored supply, distribution, and the vast majority of market share from the August 2023 cyberattack. This quarter, we drove further progress as we fully restored overall market share, grew share in most of our categories, and delivered results above our expectations, while continuing to make progress against our strategy for long-term value creation.
Best yet for investors, the company's gross profit margin improved for the eighth straight quarter, highlighting its operational turnaround seen following the cyberattack and inflation that beset the business.
While its 9% free cash flow (FCF) margins have yet to recover to their historical norm, Clorox's cash return on invested capital (ROIC) remains high at 23%. This lofty ROIC means that the company does an outstanding job of generating outsized cash flows from its debt and equity -- a trait that has proven to offer investors market-beating potential.
Powered by this steady cash generation -- even amid one of the most trying times in Clorox's history -- the company can easily fund its 3% dividend yield, with room for future payment increases. Currently, Clorox's dividend payments only use 89% of its FCF despite the fact these cash flows are yet to return to pre-pandemic levels.
After increasing its dividend payments annually for 47 straight years, Clorox is only three years away from becoming a Dividend King. Dividend Kings are a who's who of the most successful dividend growth stocks of all time and popular among investors looking for reliable passive income growth. Despite being set to join this elite company, Clorox stock only trades at 2.7 times sales today.
If it can return to its 13% FCF margins of yesteryear, the stock would be available at a reasonable 20 times FCF. This valuation compares favorably to the S&P 500's average mark of around 30.
With management guiding for long-term sales growth of 4% annually and slightly higher bottom-line growth as its operations normalize, Clorox's discounted valuation and high-yield dividend look like a safe haven in an otherwise expensive market.
Before you buy stock in Clorox, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Clorox wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $858,668!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
See the 10 stocks »
*Stock Advisor returns as of January 6, 2025
Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.